GSK plc (NYSE:GSK – Get Free Report) saw a large growth in short interest in May. As of May 15th, there was short interest totalling 10,590,000 shares, a growth of 17.8% from the April 30th total of 8,990,000 shares. Currently, 0.5% of the shares of the company are sold short. Based on an average daily […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) insider Michael Anthony White sold 28,500 shares of the business’s stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $36.24, for a total value of $1,032,840.00. The sale was disclosed in a document filed with the Securities & Exchange […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) – Equities research analysts at Capital One Financial decreased their FY2028 earnings per share estimates for shares of IDEAYA Biosciences in a research report issued to clients and investors on Thursday, May 23rd. Capital One Financial analyst T. Chiang now forecasts that the company will earn $4.37 per […]
Q2 2024 EPS Estimates for GSK plc Decreased by Zacks Research (NYSE:GSK) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
ARM (NASDAQ:ARM – Free Report) had its target price upped by Sanford C. Bernstein from $72.00 to $92.00 in a report released on Thursday, Benzinga reports. The firm currently has an underperform rating on the stock. ARM has been the topic of a number of other research reports. Barclays lifted their price target on ARM […]